// App-Quantinova.ai

: Abnormal neurodevelopment in CDH survivors is not dependent on severity or fetal surgery

Researchers

Presenter

  • Lennart Van der Veeken

Principal Investigators

  • Anna Moraes De Freire Vargas

  • Juan Otaño

  • Rashmi d’Souza

  • Francesca Maria Russo

  • Paolo De Coppi

  • Elisenda Eixarch

  • Cleisson Fabio Peralta

  • Jan Deprest

Medical Centers

  • Novartis, Barcelona, Catalonia, Spain

  • Katholieke University Leuven, Leuven, Vlaams-Brabant

  • BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Déu), Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Catalonia, Spain

  • Research Department of Maternal Fetal Medicine, Institute of Women’s Health, University College London, London, England

  • University College London, London, UK

  • Heart hospital (HCor), São Paulo, Brazil; Gestar, Fetal Medicine and Fetal Surgery Center, São Paulo, Brazil; CETRUS, São Paulo Ultrasound Training Centre, Sao Paulo, Brazil

Locations

  • Brazil

  • United Kingdom

  • Spain

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Cluster of Differentiation 44

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved